Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, GA 30602, USA.
J Chromatogr B Analyt Technol Biomed Life Sci. 2013 May 1;926:92-100. doi: 10.1016/j.jchromb.2013.03.006. Epub 2013 Mar 16.
In order to achieve a better understanding of the toxicity of drug candidates, quantitative characterization of circulatory drug metabolites has been of increasing interest in current pharmaceutical research. Stable isotope labeled (STIL) internal standards (IS) are ideally used to simplify drug metabolite quantitation via liquid chromatography and tandem mass spectrometry (LC-MS/MS) analysis, primarily due to their capability to compensate matrix effects, thereby leading to faster method establishment by using generic assay conditions. However, chemical synthesis of STIL metabolites can often be resource intensive, requiring lengthy exploratory synthesis route development and/or extensive optimization to achieve the required stability for some metabolites. To overcome these challenges, we developed a general method that could generate STIL metabolites in a matter of hours from STIL parent drugs through the utilization of an appropriate in vitro metabolic incubation. This methodology can potentially save valuable synthesis resources, as well as provide timely availability of STIL IS. The following work demonstrates the proof-of-concept that multiple STIL metabolites can be generated simultaneously to provide satisfactory performance for both absolute quantitation of drug metabolites and for potential use in assessment of relative exposure coverage across species in safety tests of drug metabolites (MIST).
为了更好地了解候选药物的毒性,当前药物研究越来越关注循环药物代谢物的定量描述。稳定同位素标记(STIL)内标(IS)通常用于通过液相色谱和串联质谱(LC-MS/MS)分析简化药物代谢物定量,主要是因为其能够补偿基质效应,从而通过使用通用检测条件更快地建立方法。然而,STIL 代谢物的化学合成通常需要大量资源,需要进行漫长的探索性合成路线开发和/或广泛的优化,以实现一些代谢物所需的稳定性。为了克服这些挑战,我们开发了一种通用方法,可通过使用适当的体外代谢孵育,在数小时内从 STIL 母体药物生成 STIL 代谢物。这种方法有可能节省宝贵的合成资源,并及时提供 STIL IS。以下工作证明了这一概念,即可以同时生成多种 STIL 代谢物,为药物代谢物的绝对定量以及在药物代谢物安全性测试(MIST)中评估种间相对暴露覆盖范围提供有价值的信息。